Results The results of the meta- analysis show an effect toward the experimental group .
Notably , prevention studies with individual psychoeducational programmes that include diet and /or physical activity seem to have the highest impact .
Conclusions When compared with treatment as usual in psychotic patients , preventive and individual lifestyle interventions that include diet and physical activity generally prove to be effective in reducing weight .
This percentage is below the 5 % to 10 % weight loss deemed sufficient to improve weight-related complications such as hypertension , type II diabetes , and dyslipidemia .
However , it is reported that outcomes associated with metabolic risk factors may have greater health implication s than weight changes alone .
Background Psychiatric patients have more physical health problems and much shorter life expectancies compared to the general population , due primarily to premature cardiovascular disease .
A multi-causal model which includes a higher prevalence of risk factors has provided a valid explanation .
It takes into consideration not only risks such as gender , age , and family history that are inherently non-modifiable , but also those such as obesity , smoking , diabetes , hypertension , and dyslipidemia that are modifiable through behavioural changes and improved care .
Thus , it is crucial to focus on factors that increase cardiovascular risk .
Obesity in particular has been associated with both the lifestyle habits and the side effects of antipsychotic medications .
The present systematic review and meta- analysis aims at collecting and updating available evidence on the efficacy of non-pharmacological health promotion programmes for psychotic patients in r and omised clinical trials .
Outcomes of obese, clozapine-treated inpatients with schizophrenia placed on a six-month diet and physical activity program.
OBJECTIVE Patients with schizophrenia treated with clozapine  often gain weight . This study evaluated the effects of dietary control and physical activity among obese in patients with schizophrenia being treated with clozapine . METHODS Fifty-three clozapine-treated obese patients with schizophrenia in a veterans hospital in eastern Taiwan who had a body mass index greater than 27 ( weight divided by height in meters squared ) and who were taking clozapine  were r and omly assigned to a study group of 28 or a control group of 25 . The study group was placed on a diet that reduced calorie intake by 200 to 300 kcal per day ( to 1,300 to 1,500 kcal per day for women and to 1,600 to 1,800 kcal per day for men ) and a six-month regimen of regular physical activity in which participants used approximately 600 to 750 kcal per week ( level walking and walking on stairs for 60 minutes three days per week ) . Anthropometric , metabolic , and hormonal parameters were measured after three and six months by using anthropometry , an enzyme autoanalyzer , immunoassay , and enzyme-linked immunosorbent assay . RESULTS Compared with the control group , the study group showed a significant decrease in body weight , body mass index ( 5.4 % reduction ) , waist circumference ( 3.3 cm ) , and hip circumference ( 3.3 cm ) after three months and after six months . Triglyceride and insulin-like growth factor-binding protein-3 ( IGFBP-3 ) decreased significantly only after six months . CONCLUSIONS A program of dietary control and regular physical activity can significantly reduce body weight and improve metabolic profiles of insulin , triglyceride , and IGFBP-3 among obese in patients taking clozapine for the treatment of schizophrenia
Results The results of the meta- analysis show an effect toward the experimental group .
Notably , prevention studies with individual psychoeducational programmes that include diet and /or physical activity seem to have the highest impact .
Conclusions When compared with treatment as usual in psychotic patients , preventive and individual lifestyle interventions that include diet and physical activity generally prove to be effective in reducing weight .
This percentage is below the 5 % to 10 % weight loss deemed sufficient to improve weight-related complications such as hypertension , type II diabetes , and dyslipidemia .
However , it is reported that outcomes associated with metabolic risk factors may have greater health implication s than weight changes alone .
Background Psychiatric patients have more physical health problems and much shorter life expectancies compared to the general population , due primarily to premature cardiovascular disease .
A multi-causal model which includes a higher prevalence of risk factors has provided a valid explanation .
It takes into consideration not only risks such as gender , age , and family history that are inherently non-modifiable , but also those such as obesity , smoking , diabetes , hypertension , and dyslipidemia that are modifiable through behavioural changes and improved care .
Thus , it is crucial to focus on factors that increase cardiovascular risk .
Obesity in particular has been associated with both the lifestyle habits and the side effects of antipsychotic medications .
The present systematic review and meta- analysis aims at collecting and updating available evidence on the efficacy of non-pharmacological health promotion programmes for psychotic patients in r and omised clinical trials .